Connect with us

Uncategorized

City of Hope receives $100 million gift to create first-of-its-kind national integrative oncology program

Photos, b-roll and video available for download in electronic media kit: https://t.ly/RRu-V. (Credit: City of Hope) Credit: Panda Restaurant Group Inc….

Published

on

Photos, b-roll and video available for download in electronic media kit: https://t.ly/RRu-V. (Credit: City of Hope)

Credit: Panda Restaurant Group Inc.

Photos, b-roll and video available for download in electronic media kit: https://t.ly/RRu-V. (Credit: City of Hope)

Event photos will be available at https://dam.gettyimages.com/assignments/city-of-hope-receives-100-million-gift.
(Event photo credit: Getty Images for City of Hope)

LOS ANGELES — City of Hope, one of the largest cancer research and treatment organizations in the United States, today announced a $100 million gift from Andrew and Peggy Cherng, philanthropists, co-founders and co-CEOs of Panda Express, to create a first-of-its-kind, national integrative oncology program that brings together Eastern and Western medicine to improve outcomes and quality of life for cancer patients and survivors.  

The gift, which will establish the Cherng Family Center for Integrative Oncology at City of Hope, is the largest single philanthropic contribution for cancer care in City of Hope history and the largest donation the Panda Charitable Family Foundation has made to any organization.

Integrative oncology is a whole-person approach to cancer care that draws from diverse cultures, particularly traditional Chinese medicine and other Eastern healing traditions. Rigorous research on Eastern therapies could result in evidence-based insights that fuel the development of more effective cancer medicines and care. 

An estimated 40% of cancer patients use integrative therapies annually to address disease and chronic issues, such as pain. Studies show integrative therapies can support better health, improved quality of life and optimal clinical outcomes. However, few health care organizations — let alone cancer centers — provide access to integrative therapies under physician supervision, much less use them holistically in treatment for patients with cancer. City of Hope will make integrative oncology an evidence-based, interwoven standard of care that supports optimal cancer treatment and survivorship.

“We are grateful for this gift, which will allow us to lead the way in integrative oncology and continue to pioneer compassionate medical innovation as we have done at City of Hope for more than 100 years,” said Robert Stone, CEO of City of Hope and the Helen and Morgan Chu Chief Executive Officer Distinguished Chair. “Innovative and holistic care is part of our culture and mission; we are committed to supporting and treating the whole patient — not just the cancer. I am honored that our cancer expertise, world-class research environment, national patient population, robust clinical trials program and compassionate ethos have prepared City of Hope to lead this work.”

“Panda Restaurant Group began 50 years ago with a vision to bring the best of Eastern and Western flavors and cultures together through food. In the same spirit, we hope the Cherng Family Center of Integrative Oncology becomes a model of bringing the best of Eastern and Western medicine together to unlock holistic healing for our communities,” said Peggy Cherng, Ph.D. “At Panda, one of our core values is giving and we are grateful to help establish, through this gift from the Panda Charitable Family Foundation, pioneering integrated cancer care to not only save lives, but improve the quality of life for cancer patients.”  

Beginning in Southern California and eventually spanning the City of Hope national system, the Cherng Family Center’s work will be led by Richard T. Lee, M.D., Cherng Family Director’s Chair for the Center for Integrative Oncology at City of Hope and one of the nation’s top integrative oncology experts. City of Hope has more than 15 years of national leadership in supportive care medicine with researchers who continue to bring forth new, evidence-based standards for preventing and managing the adverse effects of cancer and its treatment.

The Cherng Family Center for Integrative Oncology will advance the research, education and clinical care needed to ensure cancer patients and their doctors have access to safe, proven approaches in the following ways:

  • City of Hope will accelerate research, therapy development and clinical trials so scientists and physicians can develop evidence-based practices for cancer patients nationwide.
  • Education and training programs will address the shortage of knowledgeable clinicians in this field. Within the next year, City of Hope plans to create one of the first integrative oncology fellowships created and led by oncologists.
  • Programs will be piloted at City of Hope campuses in Los Angeles and Orange County, California. Experts will build scalable infrastructure and develop platforms to track clinical data to further scientific discovery and improve cancer patient outcomes. The benefits of integrative oncology will then be extended to patients throughout City of Hope’s national cancer care and research system.

“The Cherng Family Center for Integrative Oncology will be the epicenter of translational research, new drug development and holistic care that meets a pressing need for patients and enhances our connection to the diverse communities we serve,” said Edward S. Kim, M.D., M.B.A., vice physician-in-chief, City of Hope National Medical Center. “City of Hope is creating a new standard of care through a scientifically rigorous process. Our vision is to create an international destination for integrative oncology that transforms the way people with cancer receive care.” 

The Panda Charitable Family Foundation has supported City of Hope for many years, providing funding to study natural therapies as well as corporate sponsorships and donations to help pediatric cancer patients and their families.

“This visionary gift from the Cherng family is a profound testament to their generosity and continued desire to give back to the community,” said Kristin Bertell, chief philanthropy officer at City of Hope. “Donors and volunteers have powered City of Hope’s lifesaving work for more than a century, and their commitment will have a significant and lasting impact on the future of cancer care. We are so grateful to the Panda Charitable Family Foundation for its leadership in helping us create the most holistic approach to cancer care, anywhere.”

# # #

About City of Hope
City of Hope’s mission is to deliver the cures of tomorrow to the people who need them today. Founded in 1913, City of Hope has grown into one of the largest cancer research and treatment organizations in the U.S. and one of the leading research centers for diabetes and other life-threatening illnesses. City of Hope research has been the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center at its core, City of Hope brings a uniquely integrated model to patients spanning cancer care, research and development, academics and training, and innovation initiatives. City of Hope’s growing national system includes its Los Angeles campus, a network of clinical care locations across Southern California, a new cancer center in Orange County, California, and treatment facilities in Atlanta, Chicago and Phoenix. City of Hope’s affiliated group of organizations includes Translational Genomics Research Institute and AccessHopeTM. For more information about City of Hope, follow us on Facebook, Twitter, YouTube, Instagram and LinkedIn.

About Panda Charitable Family Foundation
Panda Charitable Family Foundation (PCFF) strives to create measurable and long-term impact in communities through health and education. Andrew and Peggy Cherng, the co-founders and co-CEOs of Panda Express®, established PCFF as their family foundation. Peggy Cherng, Ph.D., embraces a commitment to philanthropy as modeled by her grandmother. Her early experience instilled a spirit of giving that has become a part of her legacy. PCFF has made longstanding commitments to organizations that include Caltech, University of Missouri Columbia, University of Nevada Las Vegas, Huntington Health, Brigham and Women’s Hospital and City of Hope. These partnerships have fostered innovation in medical technology, higher education, hospitality, treatment of neurologic diseases and elevation of Eastern medicine that will impact lives across the nation. The family believes that it is an honor to give back and to model this practice for generations to follow.


Read More

Continue Reading

Uncategorized

Aging at AACR Annual Meeting 2024

BUFFALO, NY- March 11, 2024 – Impact Journals publishes scholarly journals in the biomedical sciences with a focus on all areas of cancer and aging…

Published

on

BUFFALO, NY- March 11, 2024 – Impact Journals publishes scholarly journals in the biomedical sciences with a focus on all areas of cancer and aging research. Aging is one of the most prominent journals published by Impact Journals

Credit: Impact Journals

BUFFALO, NY- March 11, 2024 – Impact Journals publishes scholarly journals in the biomedical sciences with a focus on all areas of cancer and aging research. Aging is one of the most prominent journals published by Impact Journals

Impact Journals will be participating as an exhibitor at the American Association for Cancer Research (AACR) Annual Meeting 2024 from April 5-10 at the San Diego Convention Center in San Diego, California. This year, the AACR meeting theme is “Inspiring Science • Fueling Progress • Revolutionizing Care.”

Visit booth #4159 at the AACR Annual Meeting 2024 to connect with members of the Aging team.

About Aging-US:

Aging publishes research papers in all fields of aging research including but not limited, aging from yeast to mammals, cellular senescence, age-related diseases such as cancer and Alzheimer’s diseases and their prevention and treatment, anti-aging strategies and drug development and especially the role of signal transduction pathways such as mTOR in aging and potential approaches to modulate these signaling pathways to extend lifespan. The journal aims to promote treatment of age-related diseases by slowing down aging, validation of anti-aging drugs by treating age-related diseases, prevention of cancer by inhibiting aging. Cancer and COVID-19 are age-related diseases.

Aging is indexed and archived by PubMed/Medline (abbreviated as “Aging (Albany NY)”), PubMed CentralWeb of Science: Science Citation Index Expanded (abbreviated as “Aging‐US” and listed in the Cell Biology and Geriatrics & Gerontology categories), Scopus (abbreviated as “Aging” and listed in the Cell Biology and Aging categories), Biological Abstracts, BIOSIS Previews, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).

Please visit our website at www.Aging-US.com​​ and connect with us:

  • Aging X
  • Aging Facebook
  • Aging Instagram
  • Aging YouTube
  • Aging LinkedIn
  • Aging SoundCloud
  • Aging Pinterest
  • Aging Reddit

Click here to subscribe to Aging publication updates.

For media inquiries, please contact media@impactjournals.com.


Read More

Continue Reading

Uncategorized

NY Fed Finds Medium, Long-Term Inflation Expectations Jump Amid Surge In Stock Market Optimism

NY Fed Finds Medium, Long-Term Inflation Expectations Jump Amid Surge In Stock Market Optimism

One month after the inflation outlook tracked…

Published

on

NY Fed Finds Medium, Long-Term Inflation Expectations Jump Amid Surge In Stock Market Optimism

One month after the inflation outlook tracked by the NY Fed Consumer Survey extended their late 2023 slide, with 3Y inflation expectations in January sliding to a record low 2.4% (from 2.6% in December), even as 1 and 5Y inflation forecasts remained flat, moments ago the NY Fed reported that in February there was a sharp rebound in longer-term inflation expectations, rising to 2.7% from 2.4% at the three-year ahead horizon, and jumping to 2.9% from 2.5% at the five-year ahead horizon, while the 1Y inflation outlook was flat for the 3rd month in a row, stuck at 3.0%. 

The increases in both the three-year ahead and five-year ahead measures were most pronounced for respondents with at most high school degrees (in other words, the "really smart folks" are expecting deflation soon). The survey’s measure of disagreement across respondents (the difference between the 75th and 25th percentile of inflation expectations) decreased at all horizons, while the median inflation uncertainty—or the uncertainty expressed regarding future inflation outcomes—declined at the one- and three-year ahead horizons and remained unchanged at the five-year ahead horizon.

Going down the survey, we find that the median year-ahead expected price changes increased by 0.1 percentage point to 4.3% for gas; decreased by 1.8 percentage points to 6.8% for the cost of medical care (its lowest reading since September 2020); decreased by 0.1 percentage point to 5.8% for the cost of a college education; and surprisingly decreased by 0.3 percentage point for rent to 6.1% (its lowest reading since December 2020), and remained flat for food at 4.9%.

We find the rent expectations surprising because it is happening just asking rents are rising across the country.

At the same time as consumers erroneously saw sharply lower rents, median home price growth expectations remained unchanged for the fifth consecutive month at 3.0%.

Turning to the labor market, the survey found that the average perceived likelihood of voluntary and involuntary job separations increased, while the perceived likelihood of finding a job (in the event of a job loss) declined. "The mean probability of leaving one’s job voluntarily in the next 12 months also increased, by 1.8 percentage points to 19.5%."

Mean unemployment expectations - or the mean probability that the U.S. unemployment rate will be higher one year from now - decreased by 1.1 percentage points to 36.1%, the lowest reading since February 2022. Additionally, the median one-year-ahead expected earnings growth was unchanged at 2.8%, remaining slightly below its 12-month trailing average of 2.9%.

Turning to household finance, we find the following:

  • The median expected growth in household income remained unchanged at 3.1%. The series has been moving within a narrow range of 2.9% to 3.3% since January 2023, and remains above the February 2020 pre-pandemic level of 2.7%.
  • Median household spending growth expectations increased by 0.2 percentage point to 5.2%. The increase was driven by respondents with a high school degree or less.
  • Median year-ahead expected growth in government debt increased to 9.3% from 8.9%.
  • The mean perceived probability that the average interest rate on saving accounts will be higher in 12 months increased by 0.6 percentage point to 26.1%, remaining below its 12-month trailing average of 30%.
  • Perceptions about households’ current financial situations deteriorated somewhat with fewer respondents reporting being better off than a year ago. Year-ahead expectations also deteriorated marginally with a smaller share of respondents expecting to be better off and a slightly larger share of respondents expecting to be worse off a year from now.
  • The mean perceived probability that U.S. stock prices will be higher 12 months from now increased by 1.4 percentage point to 38.9%.
  • At the same time, perceptions and expectations about credit access turned less optimistic: "Perceptions of credit access compared to a year ago deteriorated with a larger share of respondents reporting tighter conditions and a smaller share reporting looser conditions compared to a year ago."

Also, a smaller percentage of consumers, 11.45% vs 12.14% in prior month, expect to not be able to make minimum debt payment over the next three months

Last, and perhaps most humorous, is the now traditional cognitive dissonance one observes with these polls, because at a time when long-term inflation expectations jumped, which clearly suggests that financial conditions will need to be tightened, the number of respondents expecting higher stock prices one year from today jumped to the highest since November 2021... which incidentally is just when the market topped out during the last cycle before suffering a painful bear market.

Tyler Durden Mon, 03/11/2024 - 12:40

Read More

Continue Reading

Uncategorized

Homes listed for sale in early June sell for $7,700 more

New Zillow research suggests the spring home shopping season may see a second wave this summer if mortgage rates fall
The post Homes listed for sale in…

Published

on

  • A Zillow analysis of 2023 home sales finds homes listed in the first two weeks of June sold for 2.3% more. 
  • The best time to list a home for sale is a month later than it was in 2019, likely driven by mortgage rates.
  • The best time to list can be as early as the second half of February in San Francisco, and as late as the first half of July in New York and Philadelphia. 

Spring home sellers looking to maximize their sale price may want to wait it out and list their home for sale in the first half of June. A new Zillow® analysis of 2023 sales found that homes listed in the first two weeks of June sold for 2.3% more, a $7,700 boost on a typical U.S. home.  

The best time to list consistently had been early May in the years leading up to the pandemic. The shift to June suggests mortgage rates are strongly influencing demand on top of the usual seasonality that brings buyers to the market in the spring. This home-shopping season is poised to follow a similar pattern as that in 2023, with the potential for a second wave if the Federal Reserve lowers interest rates midyear or later. 

The 2.3% sale price premium registered last June followed the first spring in more than 15 years with mortgage rates over 6% on a 30-year fixed-rate loan. The high rates put home buyers on the back foot, and as rates continued upward through May, they were still reassessing and less likely to bid boldly. In June, however, rates pulled back a little from 6.79% to 6.67%, which likely presented an opportunity for determined buyers heading into summer. More buyers understood their market position and could afford to transact, boosting competition and sale prices.

The old logic was that sellers could earn a premium by listing in late spring, when search activity hit its peak. Now, with persistently low inventory, mortgage rate fluctuations make their own seasonality. First-time home buyers who are on the edge of qualifying for a home loan may dip in and out of the market, depending on what’s happening with rates. It is almost certain the Federal Reserve will push back any interest-rate cuts to mid-2024 at the earliest. If mortgage rates follow, that could bring another surge of buyers later this year.

Mortgage rates have been impacting affordability and sale prices since they began rising rapidly two years ago. In 2022, sellers nationwide saw the highest sale premium when they listed their home in late March, right before rates barreled past 5% and continued climbing. 

Zillow’s research finds the best time to list can vary widely by metropolitan area. In 2023, it was as early as the second half of February in San Francisco, and as late as the first half of July in New York. Thirty of the top 35 largest metro areas saw for-sale listings command the highest sale prices between May and early July last year. 

Zillow also found a wide range in the sale price premiums associated with homes listed during those peak periods. At the hottest time of the year in San Jose, homes sold for 5.5% more, a $88,000 boost on a typical home. Meanwhile, homes in San Antonio sold for 1.9% more during that same time period.  

 

Metropolitan Area Best Time to List Price Premium Dollar Boost
United States First half of June 2.3% $7,700
New York, NY First half of July 2.4% $15,500
Los Angeles, CA First half of May 4.1% $39,300
Chicago, IL First half of June 2.8% $8,800
Dallas, TX First half of June 2.5% $9,200
Houston, TX Second half of April 2.0% $6,200
Washington, DC Second half of June 2.2% $12,700
Philadelphia, PA First half of July 2.4% $8,200
Miami, FL First half of June 2.3% $12,900
Atlanta, GA Second half of June 2.3% $8,700
Boston, MA Second half of May 3.5% $23,600
Phoenix, AZ First half of June 3.2% $14,700
San Francisco, CA Second half of February 4.2% $50,300
Riverside, CA First half of May 2.7% $15,600
Detroit, MI First half of July 3.3% $7,900
Seattle, WA First half of June 4.3% $31,500
Minneapolis, MN Second half of May 3.7% $13,400
San Diego, CA Second half of April 3.1% $29,600
Tampa, FL Second half of June 2.1% $8,000
Denver, CO Second half of May 2.9% $16,900
Baltimore, MD First half of July 2.2% $8,200
St. Louis, MO First half of June 2.9% $7,000
Orlando, FL First half of June 2.2% $8,700
Charlotte, NC Second half of May 3.0% $11,000
San Antonio, TX First half of June 1.9% $5,400
Portland, OR Second half of April 2.6% $14,300
Sacramento, CA First half of June 3.2% $17,900
Pittsburgh, PA Second half of June 2.3% $4,700
Cincinnati, OH Second half of April 2.7% $7,500
Austin, TX Second half of May 2.8% $12,600
Las Vegas, NV First half of June 3.4% $14,600
Kansas City, MO Second half of May 2.5% $7,300
Columbus, OH Second half of June 3.3% $10,400
Indianapolis, IN First half of July 3.0% $8,100
Cleveland, OH First half of July  3.4% $7,400
San Jose, CA First half of June 5.5% $88,400

 

The post Homes listed for sale in early June sell for $7,700 more appeared first on Zillow Research.

Read More

Continue Reading

Trending